IntelGenx Technologies Corp. Joins OTCQX

NEW YORK, June 14, 2012-- OTC Markets Group Inc. (otcqx:OTCM), the financial information and technology services company that operates the world's largest OTC marketplace platform, today announced that IntelGenx Technologies Corp. (otcqx:IGXT)  CA:IGX +12.77%  , a drug delivery company, is now trading on the OTC market's highest tier, OTCQX®.

IntelGenx upgraded from OTCQB today to trade on the OTC market's prestigious tier, OTCQX U.S. Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com .

"OTCQX provides services to companies which enable them to communicate with and engage their investors, while providing them with transparent trading and easy access to company information," said R. Cromwell Coulson, President and Chief Executive Officer of OTC Markets Group. "We are pleased to welcome IntelGenx to OTCQX."

Dorsey & Whitney LLP will serve as IntelGenx' Designated Advisor for Disclosure ("DAD") on OTCQX, responsible for providing guidance on OTCQX requirements.

About IntelGenx Technologies Corp.

IntelGenx Technologies Corp. (otcqx:IGXT)  CA:IGX +12.77%  trades in the United States on OTCQX under the symbol "IGXT". IntelGenx is also trading on the TSX Venture Exchange under the symbol "IGX". IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. IntelGenx' research and development pipeline includes products for the treatment of severe depression, hypertension, erectile dysfunction, benign prostatic hyperplasia, migraine, insomnia, bipolar disorder, idiopathic pulmonary fibrosis, allergies and pain management. More information is available about the company at www.intelgenx.com .

About OTC Markets Group Inc.

OTC Markets Group Inc. (otcqx:OTCM) operates the world's largest Open, Transparent and Connected financial marketplace platform, delivering price transparency in almost 10,000 OTC securities. The OTC Link® ATS directly links broker-dealers that provide liquidity and execution services. We organize the wide spectrum of OTC-traded securities into three marketplaces to inform investors of opportunities and risks - OTCQX® - The Intelligent Marketplace for the Best OTC Companies; OTCQB® - The Venture Marketplace; and OTC Pink® - The Open Marketplace. Our financial marketplace platform enables smarter trading through any broker at the best possible price, and empowers companies to improve the quality and availability of information for their investors. To learn more about our Open, Transparent and Connected financial marketplaces, visit www.otcmarkets.com .

OTC Link ATS operated by OTC Link LLC, member FINRA/SIPC and SEC registered ATS.

Subscribe to the OTCQX RSS Feed

SOURCE OTC Markets Group Inc.

Copyright (C) 2012 PR Newswire. All rights reserved 

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.